5-Aminosalicylate (5-ASA)
https://libcat.nshealth.ca/en/permalink/chpams35397
Nova Scotia Health Authority. Central Zone. Gastroenterology.
Halifax, NS:
Nova Scotia Health Authority
, 2016.
- Pamphlet Number
- 1483
- Available Online
- View Pamphlet
5-aminosalicylate (5-ASA) is a type of drug often used to treat inflammatory bowel disease (IBD). This type of drug is good at controlling active ulcerative colitis or Crohn’s colitis as well as keeping ulcerative colitis in remission. Topics include: what 5-ASA type drugs do, which 5-ASA you should take, continuing to take the drug, talking to your doctor, what other medication you can take, and when to expect to see improvement. The pamphlet also describes common and rare side effects.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Central Zone. Gastroenterology
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2016
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (6 p.) : digital, PDF file
- Subjects (MeSH)
- Inflammatory Bowel Diseases - drug therapy
- Crohn Disease - drug therapy
- Colitis - drug therapy
- Subjects (LCSH)
- Inflammatory bowel diseases
- Crohn's disease
- Colitis
- Abstract
- 5-aminosalicylate (5-ASA) is a type of drug often used to treat inflammatory bowel disease (IBD). This type of drug is good at controlling active ulcerative colitis or Crohn’s colitis as well as keeping ulcerative colitis in remission. Topics include: what 5-ASA type drugs do, which 5-ASA you should take, continuing to take the drug, talking to your doctor, what other medication you can take, and when to expect to see improvement. The pamphlet also describes common and rare side effects.
- Responsibility
- Prepared by: Jennifer Stewart, RN; Gastroenterology
- Prepared by: Kaleigh MacIsaac, B.ScPharm; Gastroenterology
- Revised by: Phyllis Durning, RN
- Revised by: Alison Harding, B.Sc.
- Pamphlet Number
- 1483
Methotrexate (MTX) therapy for inflammatory bowel disease (IBD)
https://libcat.nshealth.ca/en/permalink/chpams34942
Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program.
Halifax, NS:
Nova Scotia Health Authority
, 2021.
- Pamphlet Number
- 1138
- Available Online
- View Pamphlet
Your health care provider feels that treatment with methotrexate (meth-oh-TREX-ate) might help your Crohn’s disease or ulcerative colitis. These are both types of inflammatory bowel disease (IBD). This pamphlet explains what methotrexate (MTX) is, how well it works, side effects of MTX, who should not take MTX, and precautions. Instructions for injecting MTX are given.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2021
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (13 p.) : digital, PDF file
- Specialty
- Gastrointestinal System
- Medications
- Abstract
- Your health care provider feels that treatment with methotrexate (meth-oh-TREX-ate) might help your Crohn’s disease or ulcerative colitis. These are both types of inflammatory bowel disease (IBD). This pamphlet explains what methotrexate (MTX) is, how well it works, side effects of MTX, who should not take MTX, and precautions. Instructions for injecting MTX are given.
- Responsibility
- Prepared by: Nova Scotia Collaborative Inflammatory Bowel Disease Program
- Pamphlet Number
- 1138
